March 26, 2020 / 10:36 AM / 8 days ago

BRIEF-Entera Bio Announces Financial And Operating Results For The Fourth Quarter And Year Ended December 31, 2019

March 26 (Reuters) - Entera Bio Ltd:

* ENTERA BIO LTD ANNOUNCES FINANCIAL AND OPERATING RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2019

* ENTERA BIO LTD - EXPECTS AN OPERATING LOSS OF BETWEEN $10 MILLION AND $12 MILLION FOR THE YEAR ENDING DEC 31, 2020

* ENTERA BIO LTD - CORPORATE OBJECTIVES FOR 2020 MAY BE MATERIALLY AND NEGATIVELY IMPACTED BY THE COVID-19

* ENTERA BIO- 3 MONTH BIOMARKER DATA FROM PHASE 2 CLINICAL TRIAL OF EB613 EXPECTED IN Q2 OF 2020 WITH ADDITIONAL DATA READOUTS EXPECTED IN 2020 & EARLY 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below